OncorpretR, a modern-age oncology platform from GenterpretR removes unpredictability from the medical management of cancers
GenterpretR is a precision medicine company that provides an immersive experience for oncologists, cancer researchers, and patients to know the disease with a 360-degree view of clinical, molecular, and drug response information.
Cancer drug response data points
Improvement in 5 years survival
Accuracy in predicting a patient's drug response
Our mission at GenterpretR is to empower oncologists, researchers and clinicians with a next-generation real-world evidence platform and AI-driven precision medicine applications based on complete mRNA and DNA genetic interpretation.
Our goal is to enable the identification of patient-specific prognostic and predictive biomarkers along with best fit targeted therapies to attack cancer cells while allowing normal cells to perform their regular functions.
Precision healthcare helps us move towards providing
the right patient
the right drug
the right dose
at the right time
GenterpretR for Clinical Oncology
Supporting clinical decisions by providing clinicians with a real-time molecular report using gene expression data and co-relation analytics with conventional bio-marker metrics
Quickly find comparable patients to understand their level of match, diagnosis, prognosis, and treatment outcomes
Real-time genetic, AI-driven clinical trials to explore alternate therapies and treatment plans
Integrated bio-marker views with therapy recommendations, explainability and actions
GenterpretR Technology Suite
A real-time search engine that delivers "comparable patients", returning matches with diagnosis, prognosis and outcomes
Hybrid inferencing AI-platform that matches a patient’s genetic profile and delivers therapy recommendations with evidence
Global oncology drug response database that aggregates distributed trials and GenterpretR clinical research data sets
GenterpretR for Research
Standardize, accelerate, and reduce the cost of drug development through Federated and Deep Learning for global and distributed clinical trials
Fast, and efficient 360 degree understanding of cancers at the clinical and molecular levels
Reaping the benefit of large scale clinical and molecular studies with help of explainable AI models
Going beyond detection of limited molecular targets with treatment prioritization for all
Who We Serve
GenterpretR serves patients by bringing knowledge and insights about personalized treatment options that will accelerate their time to being cancer-free.
GenterpretR is bringing together a multi-omics platform with global clinical trials together to choose the most effective treatment for patients.
GenterpretR’s multi-omics platform accelerates the pace of today's pharmaceutical innovation and ensures hospitals are prepared to deliver innovative medicine that can reduce treatment time.